Quick Answer
LeonaBio, Inc. reported Stockholders Equity of $27.79 million for fiscal year 2025.
LeonaBio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $27.79M | -38.0% |
| 2024 | $44.84M | -65.6% |
| 2023 | $130.19M | -44.6% |
| 2022 | $235.14M | -26.8% |
| 2021 | $321.08M | +17.1% |
| 2020 | $274.28M | +1490.7% |
| 2019 | -$19.72M | -32.5% |
| 2018 | -$14.89M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $26.79M | -53.5% | -16.3% |
| June 30, 2025 | $31.99M | -61.6% | -14.3% |
| March 31, 2025 | $37.33M | -65.0% | -16.8% |
| December 31, 2024 | $44.84M | -65.6% | -22.1% |
| September 30, 2024 | $57.58M | -62.8% | -30.9% |
| June 30, 2024 | $83.33M | -54.9% | -21.9% |
| March 31, 2024 | $106.74M | -49.4% | -18.0% |
| December 31, 2023 | $130.19M | -44.6% | -15.9% |
- LeonaBio, Inc. showed a decrease of -38.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, LeonaBio, Inc.’s stockholders equity has grown by 286.7% (from -$14.89 million to $27.79 million).
- The most recent figure is from LeonaBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: